Prognosis Association of Hypocalcemia on Moderate-severe TBI, COHORTE STUDY

Calcium , Prognosis in Patients Clinical Trial

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01236911
• Other study ID #: NCT071110
• Status: Recruiting
• Phase: N/A
• First received: November 8, 2010
• Last updated: November 8, 2010
• Start date: October 2010
• Est. completion date: November 2012

Study information

• Verified date: November 2010
• Source: Universidad Autonoma de San Luis Potosí
• Contact: Juan manuel Viñas, M.D.
• Phone: 0052 44 48 262344
• Email: weinweg21[@]hotmail.com
• Is FDA regulated: No
• Health authority: Mexico: Secretaria de Salud
• Study type: Observational

Clinical Trial Summary

Will have bad prognosis the patients with low calcium (less of 24 hrs of te admission in hospital)after moderate - severe TBI that the patients that do not developed this condition?

Description:

Through the years the investigators have seen that the patients with low calcium after moderate-severe TBI had bad prognosis including more complications, and more days in hospital. The investigators want to make an association between the patients that developed this condition and the patients that do not developed this condition

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 20
• Est. completion date: November 2012
• Est. primary completion date: September 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 16 Years to 65 Years

Eligibility

Inclusion Criteria:

• Man - woman between 16-65 years old with moderate -severe TBI less as 24 hrs,Count with tomographic study

Exclusion Criteria:

• Use of steroids, use of statins, Administration of Tromethamine, calcium antagonists, fibrates, niacin, cyclosporine, macrolides.

• Unclassifiable lesions in brainstem

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Calcium , Prognosis in Patients

Intervention

Other:
• Calcium Measurement
after moderate-severe TBI (less as 24 hrs)

Locations

Country	Name	City	State
Mexico	Juan Manuel Viñas Rios	San Luis Potosi

Sponsors (1)

Lead Sponsor	Collaborator
Universidad Autonoma de San Luis Potosí

Country where clinical trial is conducted

Mexico, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Establishment an association between the patients that developed Hypocalcemia less 24 hrs after moderate-severe TBI with patients that did not develop this condition		2 years	Yes
Secondary	Identify the more relevant prognosis factors		2 years	Yes